The Brazilian Medicines Organization Anvisa is rejecting a request from several countries for the Russian Coronary Vaccine, Sputnik V.
This is because Anvisa does not have enough technical data to verify the safety and effectiveness of the vaccine.
“We will never allow millions of Brazilians to be exposed to products without proper quality, safety and performance controls,” said Antonio Barra Torres, president of Anvisa.
Brazil is struggling to get enough vaccines. The country has a population of 212 million. Hospitals are on the verge of collapse due to the massive spread of infection.
Russia believes the decision is political.
They accuse the United States of pressuring Brazil to reject the vaccine.
Brazil has already agreed to buy 10 million doses of Sputnik V, but the vaccine must be approved first. Meanwhile, Brazil is using the AstraZeneca vaccine and the Chinese CoronaVac vaccine from Sinovac.
Brazil has signed an agreement with Pfizer to supply the vaccines, but deliveries are not expected until the end of the month. Brazil has granted emergency approval for a Johnson & Johnson Janssen vaccine, but delivery will not begin until August.
The barbecue package that gives you an interesting taste of american food
“A practicing amateur musician. Lifetime entrepreneur. Explorer. Travel fun. TV World Unapologetic. “